Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiretroviral Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced 7-step synthesis of 2-chloro-3-amino-4-picoline via patent CN101157654A. Delivers >99.7% purity for Nevirapine production with optimized cost and supply chain reliability.
Patent CN100491350C details a safe, high-yield synthesis of 5-nitroindole-2-carboxylic acid using PPA catalysis, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN106754806B discloses a high-efficiency transaminase for synthesizing (R)-3-aminobutanol, offering superior substrate tolerance and eliminating organic cosolvents for cost-effective manufacturing.
Patent CN1043646C details a high-yield d4T process avoiding hazardous reagents, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101624329B reveals a safer Triphosgene-based route for Alpha-chlorovinyl cyclopropane, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.
Patent CN110372641B reveals a novel enzymatic route for hexahydrofurofuranol derivatives, offering high optical purity and cost-effective manufacturing for API supply chains.
Patent CN107641122B reveals a scalable crystallization method replacing chromatography, offering high-purity abacavir intermediates with significant cost reduction and supply chain reliability for global API manufacturers.
Discover the patented purification method for 2-chloro-N-(2-chloro-4-methylpyridin-3-yl) nicotinamide. Achieve >99.9% purity with scalable, cost-effective crystallization.
Patent CN111484418B reveals a novel biphasic reduction method for high-purity Abacavir intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN111875510B reveals a novel continuous synthesis route for aminoacetaldehyde dimethyl acetal, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103833560B reveals a safer Zn-catalyzed route for Efavirenz intermediates. Discover cost-effective, scalable manufacturing solutions for global supply chains.
Patent CN108299428A details novel dual-target HIV inhibitors. Discover cost-effective manufacturing and supply chain solutions for high-purity pharmaceutical intermediates.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Patent CN108866028B details a mutant amino lyase for producing (R)-3-aminobutyric acid. This biocatalytic route offers superior stereoselectivity and cost efficiency for Dolutegravir intermediates.
Novel Heck reaction route for HIV drug intermediate IDX-899. High selectivity, mild conditions, scalable manufacturing solution for pharmaceutical intermediates.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Patent CN101863853B reveals a cost-effective one-pot method for 5-hydroxymethylthiazole, eliminating high-pressure hydrogenation for reliable API intermediate supply.
Patent CN115536595B enables phosphorus-free synthesis for Abacavir intermediates ensuring high purity and reduced wastewater treatment costs for global supply chains.
Patent CN104370755A reveals efficient synthesis for Dolutegravir intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.